ConductScience.org, home

Paper34857016

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.

Alors-Perez E and 25 others. J Exp Clin Cancer Res, 2021. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. Papers, record 34857016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34857016

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
PubMed
Journal
J Exp Clin Cancer Res
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
2.03
iCite
Revised in PubMed
2022-03-03
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alors-Perez EEmilia
2Blázquez-Encinas RRicardo
3Alcalá SSonia
4Viyuela-García CCristina
5Pedraza-Arevalo SSergio
6Herrero-Aguayo VVicente
7Jiménez-Vacas JMJuan M
8Mafficini AAndrea
9Sánchez-Frías MEMarina E
10Cano MTMaría T
11Abollo-Jiménez FFernando
12Marín-Sanz JAJuan A
13Cabezas-Sainz PPablo
14Lawlor RTRita T
15Luchini CClaudio
16Sánchez LLaura
17Sánchez-Hidalgo JMJuan M
18Ventura SSebastián
19Martin-Hijano LLaura
20Gahete MDManuel D

Source PubMed

See all 26 authorsDownload CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Neoplastic Stem CellsMajor topic
PhosphoproteinsMajor topic
RNA Splicing FactorsMajor topic
Adult
Aged
Animals
Disease Models, Animal
Female
Humans
Male
Mice
Middle Aged
Zebrafish

Source PubMed

Download CSV of topics

Grants18

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BFU2016-80360-RMinisterio de Economía y CompetitividadPubMed
PID2019-105201RB-I00Ministerio de Ciencia, Innovación y UniversidadesPubMed
PID2019-105564RB-I00Ministerio de Ciencia, Innovación y UniversidadesPubMed
FPU14/04290Ministerio de Ciencia, Innovación y UniversidadesPubMed
FPU18/02275Ministerio de Ciencia, Innovación y UniversidadesPubMed
FPU16/06190Ministerio de Ciencia, Innovación y UniversidadesPubMed
PI17/02287Instituto de Salud Carlos IIIPubMed
PI20/01301Instituto de Salud Carlos IIIPubMed
PI18/00757Instituto de Salud Carlos IIIPubMed
DTS20/00050Instituto de Salud Carlos IIIPubMed
CD19/00255Instituto de Salud Carlos IIIPubMed
FI17/00282Instituto de Salud Carlos IIIPubMed
GC16173694BARBFundación Científica Asociación Española Contra el CáncerPubMed
GETNE2016GETNEPubMed
GETNE2019 Research GrantGETNEPubMed
AIRC 5x1000 n. 12182Fondazione Italiana per la Ricerca sul CancroPubMed
FIMPCUP_J38D19000690001Ministero della SalutePubMed
203885/2017Fondazione Cariverona: Oncology Biobank Project "Antonio Schiavi"PubMed

Source PubMed

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132683683Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.CA Cancer J Clin2020https://conductscience.org/library/papers/32683683PubMed
229717230Therapeutic developments in pancreatic cancer: current and future perspectives.Nat Rev Gastroenterol Hepatol2018https://conductscience.org/library/papers/29717230PubMed
327158978Pancreatic cancer.Nat Rev Dis Primers2016https://conductscience.org/library/papers/27158978PubMed
426909576Genomic analyses identify molecular subtypes of pancreatic cancer.Nature2016https://conductscience.org/library/papers/26909576PubMed
532434734RNA Splicing and Cancer.Trends Cancer2020https://conductscience.org/library/papers/32434734PubMed
631611195Altered RNA Processing in Cancer Pathogenesis and Therapy.Cancer Discov2019https://conductscience.org/library/papers/31611195PubMed
732303702Roles and mechanisms of alternative splicing in cancer - implications for care.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/32303702PubMed
821178653Characterization of alternative spliceoforms and the RNA splicing machinery in pancreatic cancer.Pancreas2011https://conductscience.org/library/papers/21178653PubMed
931483163Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.DNA Cell Biol2019https://conductscience.org/library/papers/31483163PubMed
1032559497Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.Cancer Cell2020https://conductscience.org/library/papers/32559497PubMed
1131275849Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma.Front Oncol2019https://conductscience.org/library/papers/31275849PubMed
1232905346The biological function and clinical significance of SF3B1 mutations in cancer.Biomark Res2020https://conductscience.org/library/papers/32905346PubMed
1327282250RNA splicing factors as oncoproteins and tumour suppressors.Nat Rev Cancer2016https://conductscience.org/library/papers/27282250PubMed
1431344348Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.Transl Res2019https://conductscience.org/library/papers/31344348PubMed
1533038489Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma.Cancer Lett2021https://conductscience.org/library/papers/33038489PubMed
1630130664Pancreatic cancer stem cells: A state or an entity?Semin Cancer Biol2018https://conductscience.org/library/papers/30130664PubMed
1719260470Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.Hepatogastroenterology2008https://conductscience.org/library/papers/19260470PubMed
1825262208Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.Nat Methods2014https://conductscience.org/library/papers/25262208PubMed
1927578530Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.Gastroenterology2016https://conductscience.org/library/papers/27578530PubMed
2027282075RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.Mol Oncol2016https://conductscience.org/library/papers/27282075PubMed

See all 51 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42870295U2 snRNP inhibition hampers pancreatic cancer cell viability by disrupting DNA repair proficiency and mitotic checkpoint integrity.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42870295PubMed
42649859The Role of Splicing Machinery as a Promising Potential Therapeutic Target for Pituitary Neuroendocrine Tumors (PitNETs).Cancers (Basel)2026https://conductscience.org/library/papers/42649859PubMed
41986348Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer.Nat Commun2026https://conductscience.org/library/papers/41986348PubMed
41976280p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?Cancers (Basel)2026https://conductscience.org/library/papers/41976280PubMed
41228342Molecular Pathology of Pancreatic Ductal Adenocarcinoma.Cancers (Basel)2025https://conductscience.org/library/papers/41228342PubMed
41179739Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications.Bladder Cancer2025https://conductscience.org/library/papers/41179739PubMed
40702779Systematic characterization of full-length RNA isoforms in human colorectal cancer at single-cell resolution.Protein Cell2025https://conductscience.org/library/papers/40702779PubMed
40581690Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets.Acta Neuropathol Commun2025https://conductscience.org/library/papers/40581690PubMed
40563429Alternative Splicing in Tumorigenesis and Cancer Therapy.Biomolecules2025https://conductscience.org/library/papers/40563429PubMed
40301643Exploring RNA biology in pseudomyxoma peritonei uncovers splicing dysregulation as a novel, targetable molecular vulnerability.Cancer Gene Ther2025https://conductscience.org/library/papers/40301643PubMed
39885614Targeting RNA splicing modulation: new perspectives for anticancer strategy?J Exp Clin Cancer Res2025https://conductscience.org/library/papers/39885614PubMed
39725737The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer.Cell Mol Life Sci2024https://conductscience.org/library/papers/39725737PubMed
39232176The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma.Cancer Gene Ther2024https://conductscience.org/library/papers/39232176PubMed
39138145Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39138145PubMed
39000035Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features.Int J Mol Sci2024https://conductscience.org/library/papers/39000035PubMed
38904016Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target.Int J Biol Sci2024https://conductscience.org/library/papers/38904016PubMed
38790138Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.Mol Oncol2024https://conductscience.org/library/papers/38790138PubMed
38658776Alternative splicing in prostate cancer progression and therapeutic resistance.Oncogene2024https://conductscience.org/library/papers/38658776PubMed
38325381An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer.Cell Rep Med2024https://conductscience.org/library/papers/38325381PubMed
38187140Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response.Mol Ther Nucleic Acids2024https://conductscience.org/library/papers/38187140PubMed

See all 31 cited byDownload CSV of cited by

Genes36

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACTB60PubTator's text mininghttps://conductscience.org/library/genes/60NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
BAK1578PubTator's text mininghttps://conductscience.org/library/genes/578NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CCKBR887PubTator's text mininghttps://conductscience.org/library/genes/887NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
H2BC218349PubTator's text mininghttps://conductscience.org/library/genes/8349NCBI Gene
HPRT13251PubTator's text mininghttps://conductscience.org/library/genes/3251NCBI Gene
KLF49314PubTator's text mininghttps://conductscience.org/library/genes/9314NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene

See all 36 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34857016

GET https://conductscience.org/api/papers/v1/34857016/authors?page=2